Dr Devy Deliyanti receives a three year JRDF Post-doc fellowship |
The award will enable Devy to evaluate if boosting the immunosuppressive capacity of regulatory T cells improves retinal disease in type 1 diabetes. Devy will interrogate the efficacy of various treatment approaches in animal models of diabetic retinopathy and build upon her recent first author paper in Nature Communications (in press).
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.